Pulmonary Hypertension and Pregnancy

  • S. O. Siromakha National Amosov Institute of Cardiovascular Surgery of the NAMS of Ukraine, Kyiv, Ukraine; Bogomolets National Medical University, Kyiv, Ukraine https://orcid.org/0000-0002-7031-5732
  • Yu. V. Davydova National Amosov Institute of Cardiovascular Surgery of the NAMS of Ukraine, Kyiv, Ukraine; Institute of Pediatrics, Obstetrics and Gynecology named after acad. O. M. Lukianova of NAMS of Ukraine, Kyiv, Ukraine https://orcid.org/0000-0001-9747-1738
Keywords: pulmonary hypertension, pregnancy, multidisciplinary care, cardiac surgery


Pregnancy in patients with any type of pulmonary hypertension (PH) is associated with significant morbidity and mortality. That is why pulmonary artery hypertension (PAH) is a contraindication to pregnancy and belongs to class IV maternal cardiovascular risks. Maternal mortality rates for pulmonary (especially arterial) hypertension remain high even in the era of specific therapy, in particular, it reaches 12-30% in patients with PAH, 36% in Eisenmenger syndrome and up to 56% in secondary PH. Perinatal effects in such patients are also unfavorable, with high rates of fetal loss, premature birth and miscarriage.

Multidisciplinary team of specialists of the National Amosov Institute of Cardiovascular Surgery and Institute of Pediatrics, Obstetrics and Gynecology named after acad. O. M. Lukianova has been providing medical support to such women for 7 years, using modern recommendations and wide experience. Overall, 39 pregnant and parturient women with PH were admitted to the clinic of the National Amosov Institute of Cardiovascular Surgery in the period from December 2013 to October 2020. Patients with PH were assigned to group II (n=24), and those with PAH (8 women) and acute PH (7 women) were assigned to group I. A total of 20 cardiac surgeries were performed. Patients with acute PH (n=6) underwent operations with cardiopulmonary bypass, those with critical mitral valve stenosis had “closed” off-pump surgery, and also there was one case of ECMO system implantation in patient with dilated cardiomyopathy (CMP). Endovascular operations (n=4) involved occluder implantation to patent ductus arteriosus (PDA), implantation of a cardioverter-defibrillator, cardiac resynchronization therapy with pacemaker (CRT-P) and cava-filter insertion. Early (n=1) and late (n=1) maternal mortality rates were 2.6% each. Perinatal loss (n=5) was 12.8%.

The main goal at the preconception stage in patients with PH is to eliminate causative factors, and, if it is impossible (idiopathic, familial PAH, Eisenmenger syndrome, etc.), to avoid pregnancy. Patients who become pregnant should be informed of the high risk of pregnancy and discuss abortion, regardless of the WHO FC or other predictive markers. At prolongation of pregnancy careful clinical monitoring, by pregnancy heart team members is strongly recommended. Multidisciplinary support of pregnant women with PH is the cornerstone of a successful treatment strategy for such patients. The professional association of obstetric risk specialists, cardiologists, interventionists, neonatologists, and cardiac surgeons significantly increases the chances of a PH patient for safe delivery and giving birth to a healthy baby.


  1. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal. 2015 Oct;46(4):903-75. https://doi.org/10.1183/13993003.01032-2015
  2. Simonneau G, Galie` N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):S5-S12. https://doi.org/10.1016/j.jacc.2004.02.037
  3. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovas-cular diseases during pregnancy. European Heart Journal. 2018 Sep 7;39(34):3165-3241. https://doi.org/10.1093/eurheartj/ehy340
  4. Duarte AG, Thomas S, Safdar Z, Torres F, Pacheco LD, Feld-man J, et al. Management of pulmonary arterial hyperten-sion during pregnancy: a retrospective, multicenter expe-rience. Chest. 2013 May;143(5):1330-1336. https://doi.org/10.1378/chest.12-0528
  5. Podolskyi VV, Medved VI, Hutman LB, Dashkevych VIe, Davydova YuV, Avramenko TV. [High pulmonary hypertension and pregnancy. Guidelines]. Kyiv;2010. Ukrainian.
  6. Hemnes AR, Kiely DG, Cockrill BA, Safdar Z, Wilson VJ, Al Hazmi M, et al. Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research In-stitute. Pulm Circ. 2015 Sep;5(3):435-65. https://doi.org/10.1086/682230
  7. Prins KW, Thenappan T. World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology. Cardiol Clin. 2016 Aug;34(3):363-74. https://doi.org/10.1016/j.ccl.2016.04.001
  8. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004 Oct 14;351(16):1655-65. https://doi.org/10.1056/NEJMra035488
  9. [Classification, standards of diagnosis and treatment of pulmonary hypertension (in adults) of the Ukrainian Association of Cardiology (approved by the Congress of Cardiologists of Ukraine on September 28, 2018)]. Arterial?naa gipertenzia. 2018;6(62):57-66. Ukrainian. https://doi.org/10.22141/2224-1485.6.62.2018.153932
  10. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998 Jun;31(7):1650-7. https://doi.org/10.1016/s0735-1097(98)00162-4
  11. Bassily-Marcus AM, Yuan C, Oropello J, Manasia A, Kohli-Seth R, Benjamin E. Pulmonary hypertension in pregnancy: critical care management. Pulm Med. 2012;2012:709407. https://doi.org/10.1155/2012/709407
  12. Bedard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J. 2009 Feb;30(3):256-65. https://doi.org/10.1093/eurheartj/ehn597
  13. Siromakha SO, Rusnak AO, Davydova YV, Mazur OA, Kuchkova NP, Lazoryshynets VV. [Cardiac Surgery and Obstetric Strategy for Thromboembolic Complications in Pregnant Women and Parturients]. Ukrainian journal of cardiovascular surgery. 2020;(1(38)):69-74. Ukrainian. https://doi.org/10.30702/ujcvs/20.3803/010069-074
  14. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated Clinical Classification of Pulmonary Hypertension. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41. https://doi.org/10.1016/j.jacc.2013.10.029
How to Cite
Siromakha, S. O., & Davydova, Y. V. (2020). Pulmonary Hypertension and Pregnancy. Ukrainian Journal of Cardiovascular Surgery, (4 (41), 74-83. https://doi.org/10.30702/ujcvs/20.4112/055074-083/618.3